RetinalGenix Technologies (RTGN) Other Accumulated Expenses (2021 - 2026)
RetinalGenix Technologies (RTGN) posted Other Accumulated Expenses of $468428.0 for Q1 2026, down 30.59% sequentially from $674842.0 in Q4 2025, and up 164.65% YoY from $177002.0 in Q1 2025.
RetinalGenix Technologies (RTGN) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Other Accumulated Expenses for 6 years, with the latest figure at $468428.0 in Q1 2026.
- Quarterly Other Accumulated Expenses rose 164.65% year-over-year to $468428.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $468428.0 (up 164.65% YoY) and the FY2025 annual result came in at $674842.0, up 4195.89% from the prior year.
- Other Accumulated Expenses declined to $468428.0 in Q1 2026 per RTGN's latest filing, from $674842.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $811176.0 in Q2 2023 and troughed at $901.0 in Q3 2023.
- A 5-year average of $385842.3 and a median of $430309.0 in 2024 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses tumbled 99.84% in 2023, then surged 56427.08% in 2024.
- Over 5 years, Other Accumulated Expenses stood at $427933.0 in 2022, then slumped by 99.36% to $2760.0 in 2023, then surged by 469.17% to $15709.0 in 2024, then soared by 4195.89% to $674842.0 in 2025, then plunged by 30.59% to $468428.0 in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $468428.0, $674842.0, and $539052.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 468,428.00 |
| Dec 31, 2025 | 674,842.00 |
| Sep 30, 2025 | 539,052.00 |
| Jun 30, 2025 | 352,177.00 |
| Mar 31, 2025 | 177,002.00 |
| Dec 31, 2024 | 15,709.00 |
| Sep 30, 2024 | 509,309.00 |
| Jun 30, 2024 | 430,309.00 |
| Mar 31, 2024 | 193,360.00 |
| Dec 31, 2023 | 2,760.00 |
| Sep 30, 2023 | 901.00 |
| Jun 30, 2023 | 811,176.00 |
| Mar 31, 2023 | 622,806.00 |
| Dec 31, 2022 | 427,933.00 |
| Sep 30, 2022 | 561,870.00 |
| Dec 31, 2021 | 142,721.00 |